AZATHIOPRINE
- Product NDC
- 42291-071
- 11-digit product format
- 422910071
- Labeler code
- 42291
- Product ID
- 42291-071_485b4c20-1aec-8ffd-e063-6294a90a104f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Azathioprine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA074069
- Marketing category
- ANDA
- Marketing start
- 2022-01-04
- Substance
- AZATHIOPRINE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA], Nucleosides [CS], Purine Antimetabolite [EPC], Purines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- AZATHIOPRINE
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| AZATHIOPRINE | 50 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | MRK240IY2L |
| Rxcui | 197388 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 42291-071-01 | AZATHIOPRINE | 100 in 1 BOTTLE | TABLET | 100 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42291-071 | AZATHIOPRINE TABLET [AVKARE] | 6 | Current NDC, Legacy NDC, 1 package rows | 20240110_d4c7d621-9642-4027-e053-2995a90a9220.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-071-01 | 42291007101 | 100 TABLET in 1 BOTTLE (42291-071-01) | 100 tablet | 2022-01-04 | 0000-00-00 | No | No | Current |